CVRx announces outpatient payment for Barostim procedure in 2025

CVRx (CVRX) announced that the Centers for Medicare and Medicaid Services, CMS, assigned the Barostim procedure to New Technology Ambulatory Payment Classication, APC, 1580. The APC payment of approximately $45,000 will continue in 2025, as published in the 2025 Medicare Hospital Outpatient Prospective Payment System, OPPS, final rule. This follows the recent announcement that the American Medical Association CPT Editorial Panel approved the application to transition Barostim from Category III to Category I CPT codes, expected to be implemented on January 1, 2026. Additionally, as previously announced, CMS reassigned Barostim to a higher paying MS-DRG for inpatient procedures effective October 1, 2024, increasing payment to $43,000 from a previous range of $17,000-$23,000.